Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
1.860
+0.110 (6.29%)
At close: Nov 3, 2026, 4:00 PM EST
1.751
-0.109 (-5.84%)
After-hours: Nov 3, 2026, 7:30 PM EST
Alaunos Therapeutics Market Cap
Alaunos Therapeutics has a market cap or net worth of $4.73 million as of November 3, 2026. It is the 45,059th most valuable company in the world and the 6,005th biggest in the United States. Its market cap has decreased by 21.25% in one year.
Market Cap
4.73M
Enterprise Value
4.60M
1-Year Change
-21.25%
Global Rank
Country Rank
#6,005 United States
Category
ChartMarket Cap Chart
Since September 22, 2006, Alaunos Therapeutics's market cap has decreased from $76.30M to $4.73M, a decrease of -93.81%. That is a compound annual growth rate of -12.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 4.73M | -34.37% |
| Dec 31, 2025 | 7.20M | 132.26% |
| Dec 31, 2024 | 3.10M | -81.76% |
| Dec 29, 2023 | 17.00M | -87.88% |
| Dec 30, 2022 | 140.30M | -40.45% |
| Dec 31, 2021 | 235.60M | -56.37% |
| Dec 31, 2020 | 540.00M | -36.81% |
| Dec 31, 2019 | 854.50M | 220.88% |
| Dec 31, 2018 | 266.30M | -54.69% |
| Dec 29, 2017 | 587.70M | -16.61% |
| Dec 30, 2016 | 704.80M | -35.20% |
| Dec 31, 2015 | 1.09B | 108.89% |
| Dec 31, 2014 | 520.70M | 43.36% |
| Dec 31, 2013 | 363.20M | 9.66% |
| Dec 31, 2012 | 331.20M | 9.71% |
| Dec 30, 2011 | 301.90M | 33.41% |
| Dec 31, 2010 | 226.30M | 198.94% |
| Dec 31, 2009 | 75.70M | 510.48% |
| Dec 31, 2008 | 12.40M | -83.49% |
| Dec 31, 2007 | 75.10M | -17.56% |
| Dec 29, 2006 | 91.10M | 19.40% |
| Sep 22, 2006 | 76.30M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 5.32M |
| Niki BioSolutions | 5.20M |
| Senti Biosciences Holdings | 5.14M |
| Pulmatrix | 5.11M |
| Imunon | 5.11M |
| Can-Fite BioPharma | 5.08M |
| Cardio Diagnostics Holdings | 4.94M |
| Xenetic Biosciences | 4.80M |